Introduction Coronavirus disease 2019 (COVID-19) outbreak is a global health emergency caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly pathogenic human coronavirus.1 Despite the fast-growing understanding of the clinical features and natural history of COVID-19, its pathophysiology is still debated and the treatment remains largely empirical or based on observational evidence.2 Although mildly symptomatic in many cases,3 COVID-19 may be complicated by severe conditions such as adult respiratory distress syndrome (ARDS), sepsis, cardiac arrhythmias, stroke, myocardial infarction, and death.46 The thromboembolic complications may be due to both the pro-inflammatory state related to COVID-197,8 and the acute discontinuation of cardiovascular medications during hospitalization.9,10 We described the rare case of late onset concomitant myocardial infarction and stroke in COVID-19 patient who discontinued cardiovascular medications during hospitalization. A 68-year-old man with arterial hypertension and dyslipidemia was admitted to the Emergency Department (ED) of Cotugno Hospital for fever and wheezing lasting more than three days. Continue reading →

Hospital readmissions among Australian children with asthma are increasing, according to a recent study published in the Journal of Asthma in June. Continue reading →

About every 40 seconds, someone in the United States (US) has a myocardial infarction (MI).1The outcomes after MI depend on the time that elapses before treatment begins. More than half of individuals with an MI die in an emergency room or before reaching a hospital within an hour of symptom onset. Although the outcome after myocardial infarction, commonly known as Heart Attack, depends on the time to treatment, a delay between symptom onset and treatment is common Continue reading →

Zhang wins $11.2 million NIH PPG grant to improve heart attack recovery through growth of new heart muscle cells. Jianyi Jay Zhang, M.D., Ph.D.The National Institutes of Health has awarded a five-year, $11.2 million program project grant, or PPG, to Jianyi Jay Zhang, M.D., Ph.D., and colleagues to study how to restore the dead tissue from a heart attack, through the growth of new heart muscle cells Continue reading →

Dr. Lori Beth Daniels is a top-ranked physician with most experience for Acute Myocardial Infarction in California for 2022 Want to know more about Dexur's Capabilities Continue reading →

The data also suggests that social isolation and loneliness may increase during the COVID-19 pandemic, particularly among young adults aged 18-25 years, older adults, women and those on low incomes. Social isolation and loneliness is associated with an increase in The data also suggests that social isolation and loneliness may increase during the COVID-19 pandemic, particularly among young adults aged 18-25 years, older adults, women and those on low incomes. Continue reading →

August 18, 2022 A variant typical of the Finnish population that protects against heart diseases was identified in the FinnGen genomic study coordinated by the University of Helsinki. The risk of developing heart diseases is roughly one-fifth lower in carriers of the variant compared to the population on average. The protective effect of the newly discovered variant against coronary heart disease is likely to be caused by the below-average arterial stiffness of variant carriers Continue reading →

Heart failure is a leading cause of hospitalization and it is associated with an increased burden on healthcare overall [1]. Heart failure with preserved left ventricular (LV) ejection fraction (HFpEF) is defined as the presence of heart failure without any evidence of decreased LV ejection fraction [2]. Continue reading →